Skip to main content

Advertisement

SpringerLink
Log in

Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background: Unusual acute symptomatic and reversible early-delayed leukoencephalopathy has been reported to be induced by methotrexate (MTX). Objective: We aimed to identify the occurrence of such atypical MTX neurotoxicity in children and document its MR presentation. Materials and methods: We retrospectively reviewed the clinical findings and brain MRI obtained in 90 children treated with MTX for acute lymphoblastic leukaemia or non-B malignant non-Hodgkin lymphoma. All 90 patients had normal brain imaging before treatment. In these patients, brain imaging was performed after treatment completion and/or relapse and/or occurrence of neurological symptoms. Results: Of the 90 patients, 15 (16.7%) showed signs of MTX neurotoxicity on brain MRI, 9 (10%) were asymptomatic, and 6 (6.7%) showed signs of acute leukoencephalopathy. On the routine brain MRI performed at the end of treatment, all asymptomatic patients had classical MR findings of reversible MTX neurotoxicity, such as abnormal high-intensity areas localized in the deep periventricular white matter on T2-weighted images. In contrast, the six symptomatic patients had atypical brain MRI characterized by T2 high-intensity areas in the supratentorial cortex and subcortical white matter (n=6), cerebellar cortex and white matter (n=4), deep periventricular white matter (n=2) and thalamus (n=1). MR normalization occurred later than clinical recovery in these six patients. Conclusions: In addition to mostly asymptomatic classical MTX neurotoxicity, MTX may induce severe but reversible unusual leukoencephalopathy. It is important to recognize this clinicoradiological presentation in the differential diagnosis of acute neurological deterioration in children treated with MTX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abromowitch M, Ochs J, Pui CH, et al (1988) High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X. Med Pediatr Oncol 16:297–303

    Article  PubMed  CAS  Google Scholar 

  2. Keime-Guibert F, Napolitano M, Delattre JY (1998) Neurological complications of radiotherapy and chemotherapy. J Neurol 245:695–708

    Article  PubMed  CAS  Google Scholar 

  3. Yim YS, Mahoney DH Jr, Oshman DG (1991) Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer 67:2058–2061

    Article  PubMed  CAS  Google Scholar 

  4. Paakko E, Harila-Saari A, Vanionpaa L, et al (2000) White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol 35:456–461

    Article  PubMed  CAS  Google Scholar 

  5. Copeland DR (1992) Neuropsychological and psychosocial effects of childhood leukemia and its treatment. Cancer J Clin 42:283–295

    Article  CAS  Google Scholar 

  6. Paakko E, Vainionpaa L, Lanning M, et al (1992) White matter changes in children treated for acute lymphoblastic leukemia. Cancer 70:2728–2733

    Article  PubMed  CAS  Google Scholar 

  7. Paakko E, Vainionpaa L, Pyhtinen J, et al (1996) Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia. Neuroradiology 38:264–268

    PubMed  CAS  Google Scholar 

  8. Asato R, Akiyama Y, Ito M, et al (1992) Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 70:1997–2004

    Article  PubMed  CAS  Google Scholar 

  9. Shuper A, Stark B, Kornreich L, et al (2000) Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity. J Child Neurol 15:573–580

    PubMed  CAS  Google Scholar 

  10. Gay CT, Bodensteiner JB, Nitschke R, et al (1989) Reversible treatment-related leukoencephalopathy. J Child Neurol 4:208–213

    PubMed  CAS  Google Scholar 

  11. Lajtha A, Toth J, Fujimoto K, et al (1977) Turnover of myelin proteins in mouse brain in vivo. Biochem J 164:323–329

    PubMed  CAS  Google Scholar 

  12. Smith ME, Eng LF (1965) The turnover of the lipid components of myelin. J Am Oil Chem Soc 42:1013–1018

    Article  PubMed  CAS  Google Scholar 

  13. Clark AW, Cohen SR, Nissenblatt MJ, et al (1982) Paraplegia following intrathecal chemotherapy: neuropathologic findings and elevation of myelin basic protein. Cancer 50:42–47

    Article  PubMed  CAS  Google Scholar 

  14. Surtees R, Clelland J, Hann I (1998) Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. J Clin Oncol 16:1505–1511

    PubMed  CAS  Google Scholar 

  15. Lee CC, Surtees R, Duchen LW (1992) Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 115:935–955

    Article  PubMed  Google Scholar 

  16. Refsum H, Christensen B, Djurhuus R, et al (1991) Interaction between methotrexate, ‘rescue’ agents and cell proliferation as modulators of homocysteine export from cells in culture. J Pharmacol Exp Ther 258:559–566

    PubMed  CAS  Google Scholar 

  17. Quinn CT, Griener JC, Bottiglieri T, et al (1997) Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 15:2800–2806

    PubMed  CAS  Google Scholar 

  18. Quinn CT, Kamen BA (1996) A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med 44:522–530

    PubMed  CAS  Google Scholar 

  19. Wilson DA, Nitschke R, Bowman ME, et al (1991) Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology 180:205–209

    PubMed  CAS  Google Scholar 

  20. Quinn CT, Griener JC, Bottiglieri T, et al (1998) Methotrexate, homocysteine, and seizures. J Clin Oncol 16:393–394

    PubMed  CAS  Google Scholar 

  21. Maytal J, Grossman R, Yusuf FH, et al (1995) Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. Epilepsia 36:831–836

    Article  PubMed  CAS  Google Scholar 

  22. Lo Nigro L, Di Cataldo A, Schiliro G (2000) Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med Pediatr Oncol 35:449–455

    Article  PubMed  Google Scholar 

  23. Borgna-Pignatti C, Battisti L, Marradi P, et al (1992) Transient neurologic disturbances in a child treated with moderate-dose methotrexate. Br J Haematol 81:448

    PubMed  CAS  Google Scholar 

  24. Sandoval C, Kutscher M, Jayabose S, et al (2003) Neurotoxicity of intrathecal methotrexate: MR imaging findings. Am J Neuroradiol 24:1887–1890

    PubMed  Google Scholar 

  25. Hellwig B (1993) How the myelin picture of the human cerebral cortex can be computed from cytoarchitectural data. A bridge between von Economo and Vogt. Hirnforsch J 34:387–402

    CAS  Google Scholar 

  26. Peters A (2002) The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol 31:581–593

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Queen Fabiola Children's University Hospital, Avenue J J Crocq, 15, 1020, Brussels, Belgium

    France Ziereisen, Nash Damry & Catherine Christophe

  2. Department of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium

    Bernard Dan

  3. Department of Paediatrics, Queen Fabiola Children's University Hospital, Brussels, Belgium

    Nadira Azzi & Alina Ferster

Authors
  1. France Ziereisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard Dan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadira Azzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alina Ferster
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nash Damry
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Catherine Christophe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to France Ziereisen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziereisen, F., Dan, B., Azzi, N. et al. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features. Pediatr Radiol 36, 205–212 (2006). https://doi.org/10.1007/s00247-005-0015-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-005-0015-z

Keywords

Search

Navigation